JULPHAR
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) on Monday announced signing an agreement with medical technology company BD, Becton, Dickinson and Company (BD), to supply disposable insulin pens in the UAE.
The deal will contribute to enhancing Julphar’s position in the Emarati market, the firm’s general manager Jerome Carle said.
“The global diabetes market is large and growing,” Carle added.
Under this contract, Julphar’s human insulin formulations that include Jusline R, Jusline N, and Jusline 30/70 will be available through BD’s portfolio of BD Vystra™ disposable pens.
“The same device will be used for insulin analogues (insulin glargine and insulin lispro), which are still under development,” according to Julphar’s statement.